Ovis aries strain OAR_USU_Benz2616 breed Rambouillet chromosome 26, ARS-UI_Ramb_v2.0, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; Caprinae; Ovis.
REFSEQ INFORMATION: The reference sequence is identical to\nCM028729.1.\nAssembly name: ARS-UI_Ramb_v2.0\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the University of Idaho on\n2021/02/03. The original whole-genome shotgun project has the\naccession JAEVFA000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: University of Idaho\nAssembly Date :: NOV-2020\nAssembly Method :: Canu v. 1.8; Nanopolish v. 0.12.5; Salsa\n v. 2.2; PB Jelly v. 15.8.24; Freebayes v.\n 1.3.1\nAssembly Name :: ARS-UI_Ramb_v2.0\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 55.0x\nSequencing Technology :: Oxford Nanopore PromethION; PacBio RSII;\n Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Ovis aries Annotation Release 104\nAnnotation Version :: 104\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
non-histone chromosomal protein HMG-14, transcript variant X2
COORDINATES: cap analysis [ECO:0007248] and polyA evidence [ECO:0006239]
non-histone chromosomal protein HMG-14, transcript variant X1
non-histone chromosomal protein HMG-14 isoform X2
non-histone chromosomal protein HMG-14 isoform X1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
COORDINATES: polyA evidence [ECO:0006239]
CLN8 transmembrane ER and ERGIC protein, transcript variant X2
CLN8 transmembrane ER and ERGIC protein, transcript variant X3
CLN8 transmembrane ER and ERGIC protein, transcript variant X4
CLN8 transmembrane ER and ERGIC protein, transcript variant X1
CUB and sushi domain-containing protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CUB and sushi domain-containing protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
CUB and sushi domain-containing protein 1-like, transcript variant X4
CUB and sushi domain-containing protein 1-like, transcript variant X2
CUB and sushi domain-containing protein 1-like
Rho guanine nucleotide exchange factor 10, transcript variant X1
Rho guanine nucleotide exchange factor 10, transcript variant X2
Rho guanine nucleotide exchange factor 10, transcript variant X3
Rho guanine nucleotide exchange factor 10, transcript variant X4
rho guanine nucleotide exchange factor 10 isoform X1
rho guanine nucleotide exchange factor 10 isoform X2
rho guanine nucleotide exchange factor 10 isoform X3
rho guanine nucleotide exchange factor 10 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
kelch repeat and BTB domain containing 11
kelch repeat and BTB domain-containing protein 11
CUB and sushi domain-containing protein 1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon GGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
transfer RNA glycine (anticodon CCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
1-acylglycerol-3-phosphate O-acyltransferase 5, transcript variant X2
1-acylglycerol-3-phosphate O-acyltransferase 5, transcript variant X1
1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon isoform X1
1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon isoform X2
zinc finger protein 596, transcript variant X2
zinc finger protein 596, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 51% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 90 member A26
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
uncharacterized LOC105605768, transcript variant X3
uncharacterized LOC105605768, transcript variant X1
uncharacterized LOC105605768, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 79% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 705A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger protein 705A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins
zinc finger protein 705A-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zinc finger protein 705A-like, transcript variant X13
zinc finger protein 705A-like, transcript variant X8
zinc finger protein 705A-like, transcript variant X4
zinc finger protein 705A-like, transcript variant X9
zinc finger protein 705A-like, transcript variant X12
zinc finger protein 705A-like, transcript variant X7
zinc finger protein 705A-like, transcript variant X10
zinc finger protein 705A-like, transcript variant X16
zinc finger protein 705A-like, transcript variant X15
zinc finger protein 705A-like, transcript variant X14
zinc finger protein 705A-like, transcript variant X6
zinc finger protein 705A-like, transcript variant X11
zinc finger protein 705A-like, transcript variant X5
zinc finger protein 705A-like isoform X1
zinc finger protein 705A-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
beta defensin 2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001198545.1
annotated by transcript or proteomic data
The RefSeq transcript has 1 substitution compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001185474.1
The RefSeq protein has 1 substitution compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
COORDINATES: ab initio prediction:SignalP:4.0
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121818087, transcript variant X2
uncharacterized LOC121818087, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC121816030, transcript variant X2
uncharacterized LOC121816030, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 84% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121818090, transcript variant X2
uncharacterized LOC121818090, transcript variant X1
neuronal membrane glycoprotein M6-a isoform X2
neuronal membrane glycoprotein M6-a isoform X1
neuronal membrane glycoprotein M6-a isoform X3
WD repeat domain 17, transcript variant X1
WD repeat domain 17, transcript variant X2
WD repeat domain 17, transcript variant X5
WD repeat domain 17, transcript variant X6
WD repeat domain 17, transcript variant X4
WD repeat domain 17, transcript variant X3
WD repeat domain 17, transcript variant X7
WD repeat domain 17, transcript variant X8
WD repeat-containing protein 17 isoform X1
WD repeat-containing protein 17 isoform X2
WD repeat-containing protein 17 isoform X5
WD repeat-containing protein 17 isoform X6
WD repeat-containing protein 17 isoform X4
WD repeat-containing protein 17 isoform X8
WD repeat-containing protein 17 isoform X3
WD repeat-containing protein 17 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 63% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat and SOCS box containing 5, transcript variant X1
ankyrin repeat and SOCS box containing 5, transcript variant X2
ankyrin repeat and SOCS box containing 5, transcript variant X3
ankyrin repeat and SOCS box protein 5 isoform X1
ankyrin repeat and SOCS box protein 5 isoform X2
ankyrin repeat and SOCS box protein 5 isoform X3
uncharacterized LOC121818025, transcript variant X1
uncharacterized LOC121818025, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC121818025, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC121818026, transcript variant X1
uncharacterized LOC121818026, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC121818026, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC121818026, transcript variant X8
uncharacterized LOC121818026, transcript variant X2
uncharacterized LOC121818026, transcript variant X3
uncharacterized LOC121818026, transcript variant X4
uncharacterized LOC121818026, transcript variant X5
vascular endothelial growth factor C, transcript variant X1
vascular endothelial growth factor C, transcript variant X3
vascular endothelial growth factor C, transcript variant X2
vascular endothelial growth factor C isoform X1
vascular endothelial growth factor C isoform X2
vascular endothelial growth factor C isoform X3
uncharacterized LOC121818101, transcript variant X2
uncharacterized LOC121818101, transcript variant X1
uncharacterized LOC121818101, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
COORDINATES: nucleotide motif:Rfam:12.0:RF00099
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 19% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC105605134
teneurin transmembrane protein 3, transcript variant X1
teneurin transmembrane protein 3, transcript variant X2
teneurin transmembrane protein 3, transcript variant X3
teneurin transmembrane protein 3, transcript variant X4
teneurin transmembrane protein 3, transcript variant X5
teneurin transmembrane protein 3, transcript variant X6
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC106990149, transcript variant X1
uncharacterized LOC106990149, transcript variant X2
WW and C2 domain containing 2, transcript variant X1
WW and C2 domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments
CDKN2A interacting protein, transcript variant X1
CDKN2A interacting protein, transcript variant X2
CDKN2A interacting protein, transcript variant X3
RWD domain containing 4, transcript variant X1
RWD domain containing 4, transcript variant X2
RWD domain-containing protein 4 isoform X1
RWD domain-containing protein 4 isoform X2
trafficking protein particle complex subunit 11
ectonucleotide pyrophosphatase/phosphodiesterase 6, transcript variant X2
ectonucleotide pyrophosphatase/phosphodiesterase 6, transcript variant X1
glycerophosphocholine cholinephosphodiesterase ENPP6 isoform X2
glycerophosphocholine cholinephosphodiesterase ENPP6 isoform X1
interferon regulatory factor 2; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
interferon regulatory factor 2, transcript variant X3
interferon regulatory factor 2, transcript variant X4
interferon regulatory factor 2, transcript variant X2
interferon regulatory factor 2, transcript variant X1
interferon regulatory factor 2 isoform X1
Derived by automated computational analysis using gene prediction method: BestRefSeq.
interferon regulatory factor 2 isoform X2
interferon regulatory factor 2, transcript variant X5
interferon regulatory factor 2 isoform X3
primase and DNA directed polymerase, transcript variant X2
primase and DNA directed polymerase, transcript variant X4
primase and DNA directed polymerase, transcript variant X1
primase and DNA directed polymerase, transcript variant X5
primase and DNA directed polymerase, transcript variant X3
DNA-directed primase/polymerase protein isoform X1
DNA-directed primase/polymerase protein isoform X3
DNA-directed primase/polymerase protein isoform X2
primase and DNA directed polymerase, transcript variant X6
DNA-directed primase/polymerase protein isoform X4
centromere protein U, transcript variant X2
centromere protein U, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: 60S ribosomal protein L7
acyl-CoA synthetase long chain family member 1, transcript variant X4
acyl-CoA synthetase long chain family member 1, transcript variant X3
acyl-CoA synthetase long chain family member 1, transcript variant X1
acyl-CoA synthetase long chain family member 1, transcript variant X5
acyl-CoA synthetase long chain family member 1, transcript variant X2
long-chain-fatty-acid--CoA ligase 1 isoform X2
long-chain-fatty-acid--CoA ligase 1 isoform X1
transfer RNA cysteine (anticodon ACA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
hairy and enhancer of split-related protein HELT
solute carrier family 25 member 4; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001127278.1
The RefSeq transcript has 3 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001120750.1
The RefSeq protein has 2 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
cilia and flagella associated protein 97, transcript variant X2
cilia and flagella associated protein 97, transcript variant X1
cilia and flagella associated protein 97, transcript variant X3
cilia- and flagella-associated protein 97
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 70% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat domain 37, transcript variant X1
ankyrin repeat domain 37, transcript variant X4
ankyrin repeat domain 37, transcript variant X3
ankyrin repeat domain 37, transcript variant X2
ankyrin repeat domain 37, transcript variant X5
ankyrin repeat domain-containing protein 37 isoform X1
ankyrin repeat domain-containing protein 37 isoform X4
ankyrin repeat domain-containing protein 37 isoform X3
ankyrin repeat domain-containing protein 37 isoform X2
ankyrin repeat domain-containing protein 37 isoform X5
chromosome 26 C4orf47 homolog, transcript variant X1
chromosome 26 C4orf47 homolog, transcript variant X2
UPF0602 protein C4orf47 homolog isoform X2
UPF0602 protein C4orf47 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 75% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 110
PDZ and LIM domain 3, transcript variant X3
PDZ and LIM domain 3, transcript variant X1
PDZ and LIM domain 3, transcript variant X2
transfer RNA glycine (anticodon ACC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
sorbin and SH3 domain-containing protein 2, transcript variant X13
sorbin and SH3 domain-containing protein 2, transcript variant X18
sorbin and SH3 domain-containing protein 2, transcript variant X6
sorbin and SH3 domain-containing protein 2, transcript variant X14
sorbin and SH3 domain-containing protein 2, transcript variant X8
sorbin and SH3 domain-containing protein 2, transcript variant X11
sorbin and SH3 domain-containing protein 2, transcript variant X16
sorbin and SH3 domain-containing protein 2, transcript variant X4
sorbin and SH3 domain-containing protein 2, transcript variant X9
sorbin and SH3 domain-containing protein 2, transcript variant X12
sorbin and SH3 domain-containing protein 2, transcript variant X5
sorbin and SH3 domain-containing protein 2, transcript variant X17
sorbin and SH3 domain-containing protein 2, transcript variant X7
sorbin and SH3 domain-containing protein 2, transcript variant X19
sorbin and SH3 domain-containing protein 2, transcript variant X3
sorbin and SH3 domain-containing protein 2, transcript variant X10
sorbin and SH3 domain-containing protein 2, transcript variant X21
sorbin and SH3 domain-containing protein 2, transcript variant X2
sorbin and SH3 domain-containing protein 2, transcript variant X30
sorbin and SH3 domain-containing protein 2, transcript variant X1
sorbin and SH3 domain-containing protein 2, transcript variant X24
sorbin and SH3 domain-containing protein 2, transcript variant X23
sorbin and SH3 domain-containing protein 2, transcript variant X22
sorbin and SH3 domain-containing protein 2, transcript variant X20
sorbin and SH3 domain-containing protein 2, transcript variant X26
sorbin and SH3 domain-containing protein 2, transcript variant X15
sorbin and SH3 domain-containing protein 2, transcript variant X29
sorbin and SH3 domain-containing protein 2, transcript variant X25
sorbin and SH3 domain-containing protein 2, transcript variant X28
sorbin and SH3 domain-containing protein 2, transcript variant X27
sorbin and SH3 domain-containing protein 2 isoform X8
sorbin and SH3 domain-containing protein 2 isoform X3
sorbin and SH3 domain-containing protein 2 isoform X5
sorbin and SH3 domain-containing protein 2 isoform X10
sorbin and SH3 domain-containing protein 2 isoform X2
sorbin and SH3 domain-containing protein 2 isoform X19
sorbin and SH3 domain-containing protein 2 isoform X1
sorbin and SH3 domain-containing protein 2 isoform X13
sorbin and SH3 domain-containing protein 2 isoform X12
sorbin and SH3 domain-containing protein 2 isoform X11
sorbin and SH3 domain-containing protein 2 isoform X9
sorbin and SH3 domain-containing protein 2 isoform X15
sorbin and SH3 domain-containing protein 2 isoform X7
sorbin and SH3 domain-containing protein 2 isoform X4
sorbin and SH3 domain-containing protein 2 isoform X6
sorbin and SH3 domain-containing protein 2 isoform X18
sorbin and SH3 domain-containing protein 2 isoform X14
sorbin and SH3 domain-containing protein 2 isoform X17
sorbin and SH3 domain-containing protein 2 isoform X16
toll like receptor 3; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
toll like receptor 3, transcript variant X1
toll like receptor 3, transcript variant X2
family with sequence similarity 149 member A, transcript variant X1
family with sequence similarity 149 member A, transcript variant X2
uncharacterized LOC114111046, transcript variant X3
uncharacterized LOC114111046, transcript variant X1
uncharacterized LOC114111046, transcript variant X2
uncharacterized LOC114111046, transcript variant X4
cytochrome P450 4V2, transcript variant X1
cytochrome P450 4V2, transcript variant X2
melatonin receptor 1A; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001009725.1
The RefSeq transcript has 11 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001009725.1
The RefSeq protein has 3 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (P48040.1); glycosylation site
propagated from UniProtKB/Swiss-Prot (P48040.1); transmembrane region
FAT atypical cadherin 1, transcript variant X2
FAT atypical cadherin 1, transcript variant X7
FAT atypical cadherin 1, transcript variant X5
FAT atypical cadherin 1, transcript variant X6
FAT atypical cadherin 1, transcript variant X4
FAT atypical cadherin 1, transcript variant X1
FAT atypical cadherin 1, transcript variant X3
FAT atypical cadherin 1, transcript variant X8
FAT atypical cadherin 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments
probable E3 ubiquitin-protein ligase TRIML2
probable E3 ubiquitin-protein ligase TRIML1
COORDINATES: nucleotide motif:Rfam:12.0:RF01241
COORDINATES: nucleotide motif:Rfam:12.0:RF00494
COORDINATES: nucleotide motif:Rfam:12.0:RF00493
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
N-acylsphingosine amidohydrolase 1, transcript variant X2
N-acylsphingosine amidohydrolase 1, transcript variant X1
pericentriolar material 1, transcript variant X18
pericentriolar material 1, transcript variant X17
pericentriolar material 1, transcript variant X16
pericentriolar material 1, transcript variant X19
pericentriolar material 1, transcript variant X13
pericentriolar material 1, transcript variant X12
pericentriolar material 1, transcript variant X14
pericentriolar material 1, transcript variant X10
pericentriolar material 1 protein isoform X15
pericentriolar material 1 protein isoform X14
pericentriolar material 1 protein isoform X13
pericentriolar material 1 protein isoform X16
pericentriolar material 1 protein isoform X10
pericentriolar material 1 protein isoform X9
pericentriolar material 1 protein isoform X11
pericentriolar material 1 protein isoform X7
pericentriolar material 1, transcript variant X2
pericentriolar material 1, transcript variant X4
pericentriolar material 1, transcript variant X9
pericentriolar material 1, transcript variant X15
pericentriolar material 1, transcript variant X11
pericentriolar material 1, transcript variant X7
pericentriolar material 1, transcript variant X5
pericentriolar material 1, transcript variant X6
pericentriolar material 1, transcript variant X8
pericentriolar material 1, transcript variant X1
pericentriolar material 1, transcript variant X3
pericentriolar material 1 protein isoform X6
pericentriolar material 1 protein isoform X12
pericentriolar material 1 protein isoform X8
pericentriolar material 1 protein isoform X4
pericentriolar material 1 protein isoform X2
pericentriolar material 1 protein isoform X3
pericentriolar material 1 protein isoform X5
pericentriolar material 1 protein isoform X1
metalloreductase STEAP1, transcript variant X2
metalloreductase STEAP1, transcript variant X1
pericentriolar material 1, transcript variant X20
pericentriolar material 1 protein isoform X17
microtubule associated scaffold protein 1, transcript variant X3
microtubule associated scaffold protein 1, transcript variant X4
microtubule associated scaffold protein 1, transcript variant X5
microtubule associated scaffold protein 1, transcript variant X2
microtubule associated scaffold protein 1, transcript variant X1
microtubule associated scaffold protein 1, transcript variant X6
microtubule associated scaffold protein 1, transcript variant X7
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
microtubule-associated tumor suppressor 1 isoform X1
microtubule-associated tumor suppressor 1 isoform X2
microtubule-associated tumor suppressor 1 isoform X3
microtubule associated scaffold protein 1, transcript variant X8
microtubule-associated tumor suppressor 1 isoform X4
microtubule associated scaffold protein 1, transcript variant X9
microtubule-associated tumor suppressor 1 isoform X5
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
microtubule associated scaffold protein 1, transcript variant X10
microtubule-associated tumor suppressor 1 isoform X6
platelet derived growth factor receptor like
platelet-derived growth factor receptor-like protein
solute carrier family 7 member 2, transcript variant X2
solute carrier family 7 member 2, transcript variant X1
cationic amino acid transporter 2 isoform X2
cationic amino acid transporter 2 isoform X1
myotubularin related protein 7, transcript variant X3
myotubularin related protein 7, transcript variant X1
myotubularin related protein 7, transcript variant X2
myotubularin-related protein 7 isoform X3
myotubularin-related protein 7 isoform X1
myotubularin-related protein 7 isoform X2
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
vacuolar protein sorting-associated protein 37A
U6 snRNA-associated Sm-like protein LSm5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
CCR4-NOT transcription complex subunit 7, transcript variant X4
CCR4-NOT transcription complex subunit 7, transcript variant X2
CCR4-NOT transcription complex subunit 7, transcript variant X3
CCR4-NOT transcription complex subunit 7, transcript variant X1
CCR4-NOT transcription complex subunit 7, transcript variant X5
CCR4-NOT transcription complex subunit 7 isoform X1
CCR4-NOT transcription complex subunit 7 isoform X2
zinc finger DHHC-type palmitoyltransferase 2, transcript variant X2
zinc finger DHHC-type palmitoyltransferase 2, transcript variant X1
mitochondrial calcium uptake family member 3, transcript variant X2
mitochondrial calcium uptake family member 3, transcript variant X1
calcium uptake protein 3, mitochondrial isoform X2
calcium uptake protein 3, mitochondrial isoform X1
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
macrophage scavenger receptor 1, transcript variant X2
macrophage scavenger receptor 1, transcript variant X1
macrophage scavenger receptor 1, transcript variant X3
macrophage scavenger receptor types I and II isoform X1
macrophage scavenger receptor types I and II isoform X2
tumor suppressor candidate 3, transcript variant X6
tumor suppressor candidate 3, transcript variant X5
tumor suppressor candidate 3, transcript variant X4
tumor suppressor candidate 3, transcript variant X3
tumor suppressor candidate 3, transcript variant X2
tumor suppressor candidate 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
DLC1 Rho GTPase activating protein, transcript variant X2
DLC1 Rho GTPase activating protein, transcript variant X3
DLC1 Rho GTPase activating protein, transcript variant X1
rho GTPase-activating protein 7 isoform X1
DLC1 Rho GTPase activating protein, transcript variant X5
rho GTPase-activating protein 7 isoform X3
2-iminobutanoate/2-iminopropanoate deaminase-like
DLC1 Rho GTPase activating protein, transcript variant X4
DLC1 Rho GTPase activating protein, transcript variant X6
rho GTPase-activating protein 7 isoform X2
rho GTPase-activating protein 7 isoform X4
tRNA methyltransferase 9B (putative), transcript variant X2
tRNA methyltransferase 9B (putative), transcript variant X5
tRNA methyltransferase 9B (putative), transcript variant X1
tRNA methyltransferase 9B (putative), transcript variant X3
tRNA methyltransferase 9B (putative), transcript variant X4
probable tRNA methyltransferase 9B isoform X1
probable tRNA methyltransferase 9B isoform X2
LON peptidase N-terminal domain and ring finger 1, transcript variant X2
LON peptidase N-terminal domain and ring finger 1, transcript variant X1
LON peptidase N-terminal domain and RING finger protein 1
PEAK1 related, kinase-activating pseudokinase 1, transcript variant X1
PEAK1 related, kinase-activating pseudokinase 1, transcript variant X2
PEAK1 related, kinase-activating pseudokinase 1, transcript variant X3
very low-density lipoprotein receptor-like
low-density lipoprotein receptor-related protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 89% coverage of the annotated genomic feature by RNAseq alignments
multifunctional ROCO family signaling regulator 1, transcript variant X2
multifunctional ROCO family signaling regulator 1, transcript variant X1
malignant fibrous histiocytoma-amplified sequence 1 isoform X1
malignant fibrous histiocytoma-amplified sequence 1 isoform X2
multifunctional ROCO family signaling regulator 1, transcript variant X3
malignant fibrous histiocytoma-amplified sequence 1 isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00408
exoribonuclease 1, transcript variant X1
exoribonuclease 1, transcript variant X2
protein phosphatase 1 regulatory subunit 3B, transcript variant X1
protein phosphatase 1 regulatory subunit 3B, transcript variant X2
protein phosphatase 1 regulatory subunit 3B isoform X1
protein phosphatase 1 regulatory subunit 3B isoform X2
poly [ADP-ribose] polymerase tankyrase-1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin carboxyl-terminal hydrolase 11-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 12 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ubiquitin carboxyl-terminal hydrolase 11-like
store-operated calcium entry associated regulatory factor
store-operated calcium entry-associated regulatory factor
leptin receptor overlapping transcript like 1
leptin receptor overlapping transcript-like 1
membrane bound O-acyltransferase domain containing 4; Derived by automated computational analysis using gene prediction method: BestRefSeq.
membrane bound O-acyltransferase domain containing 4
similar to RNA sequence, mRNA (same species):RefSeq:NM_001306122.1
The RefSeq transcript has 13 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001293051.1
The RefSeq protein has 6 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
RNA binding protein, mRNA processing factor, transcript variant X8
RNA binding protein, mRNA processing factor, transcript variant X2
RNA binding protein, mRNA processing factor, transcript variant X3
RNA binding protein, mRNA processing factor, transcript variant X1
RNA binding protein, mRNA processing factor, transcript variant X5
RNA binding protein, mRNA processing factor, transcript variant X4
RNA binding protein, mRNA processing factor, transcript variant X9
RNA binding protein, mRNA processing factor, transcript variant X6
RNA binding protein, mRNA processing factor, transcript variant X7
RNA-binding protein with multiple splicing isoform X4
RNA-binding protein with multiple splicing isoform X1
RNA-binding protein with multiple splicing isoform X5
RNA-binding protein with multiple splicing isoform X2
RNA-binding protein with multiple splicing isoform X3
general transcription factor IIE subunit 2, transcript variant X1
transcription initiation factor IIE subunit beta isoform X1
general transcription factor IIE subunit 2, transcript variant X2
general transcription factor IIE subunit 2, transcript variant X3
transcription initiation factor IIE subunit beta isoform X2
transcription initiation factor IIE subunit beta isoform X3
small integral membrane protein 18, transcript variant X1
small integral membrane protein 18, transcript variant X2
UBX domain protein 8, transcript variant X1
UBX domain protein 8, transcript variant X2
UBX domain-containing protein 8 isoform X1
UBX domain-containing protein 8 isoform X2
protein phosphatase 2 catalytic subunit beta
serine/threonine-protein phosphatase 2A catalytic subunit beta isoform
testis expressed 15, meiosis and synapsis associated
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
purine rich element binding protein G, transcript variant X2
purine-rich element-binding protein gamma isoform X2
purine rich element binding protein G, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
purine-rich element-binding protein gamma isoform X3
purine rich element binding protein G, transcript variant X1
purine-rich element-binding protein gamma isoform X1
WRN RecQ like helicase, transcript variant X8
WRN RecQ like helicase, transcript variant X2
WRN RecQ like helicase, transcript variant X1
WRN RecQ like helicase, transcript variant X4
WRN RecQ like helicase, transcript variant X3
WRN RecQ like helicase, transcript variant X5
WRN RecQ like helicase, transcript variant X7
Werner syndrome ATP-dependent helicase isoform X1
Werner syndrome ATP-dependent helicase isoform X2
Werner syndrome ATP-dependent helicase isoform X4
Werner syndrome ATP-dependent helicase isoform X3
Werner syndrome ATP-dependent helicase isoform X5
WRN RecQ like helicase, transcript variant X6
Werner syndrome ATP-dependent helicase isoform X6
Werner syndrome ATP-dependent helicase isoform X7
WRN RecQ like helicase, transcript variant X9
Werner syndrome ATP-dependent helicase isoform X8
pro-neuregulin-2, membrane-bound isoform-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 long SRA reads, and 71% coverage of the annotated genomic feature by RNAseq alignments
pro-neuregulin-1, membrane-bound isoform isoform X5
pro-neuregulin-1, membrane-bound isoform isoform X4
pro-neuregulin-1, membrane-bound isoform isoform X6
pro-neuregulin-1, membrane-bound isoform isoform X7
pro-neuregulin-1, membrane-bound isoform isoform X8
pro-neuregulin-1, membrane-bound isoform isoform X11
pro-neuregulin-1, membrane-bound isoform isoform X12
pro-neuregulin-1, membrane-bound isoform isoform X2
pro-neuregulin-1, membrane-bound isoform isoform X1
pro-neuregulin-1, membrane-bound isoform isoform X3
pro-neuregulin-3, membrane-bound isoform isoform X10
pro-neuregulin-1, membrane-bound isoform isoform X9
pro-neuregulin-1, membrane-bound isoform isoform X13
pro-neuregulin-1, membrane-bound isoform isoform X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
fucosyltransferase 10, transcript variant X1
alpha-(1,3)-fucosyltransferase 10 isoform X1
fucosyltransferase 10, transcript variant X2
alpha-(1,3)-fucosyltransferase 10 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 37% coverage of the annotated genomic feature by RNAseq alignments
TELO2 interacting protein 2, transcript variant X1
TELO2 interacting protein 2, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF01210
ring finger protein 122, transcript variant X2
ring finger protein 122, transcript variant X1
uncharacterized LOC105606408, transcript variant X1
uncharacterized LOC105606408, transcript variant X2
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
COORDINATES: nucleotide motif:Rfam:12.0:RF00432
unc-5 netrin receptor D, transcript variant X1
unc-5 netrin receptor D, transcript variant X3
unc-5 netrin receptor D, transcript variant X2
unc-5 netrin receptor D, transcript variant X4
unc-5 netrin receptor D, transcript variant X6
unc-5 netrin receptor D, transcript variant X5
coiled-coil domain-containing protein 25-like
potassium calcium-activated channel subfamily U member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 50% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
ER lipid raft associated 2, transcript variant X1
ER lipid raft associated 2, transcript variant X3
ER lipid raft associated 2, transcript variant X2
pyridoxal phosphate binding protein, transcript variant X1
pyridoxal phosphate binding protein, transcript variant X2
pyridoxal phosphate homeostasis protein isoform X1
pyridoxal phosphate homeostasis protein isoform X2
BRF2 RNA polymerase III transcription initiation factor subunit
transcription factor IIIB 50 kDa subunit
RAB11 family interacting protein 1, transcript variant X2
RAB11 family interacting protein 1, transcript variant X1
rab11 family-interacting protein 1 isoform X2
rab11 family-interacting protein 1 isoform X1
glutamic-oxaloacetic transaminase 1 like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
putative aspartate aminotransferase, cytoplasmic 2
adrenoceptor beta 3; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001159757.1
The RefSeq transcript has 6 substitutions, 1 non-frameshifting indel compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001153229.1
G-protein coupled receptor with seven transmembrane regions; The RefSeq protein has 1 substitution compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (Q9XT58.2); glycosylation site
propagated from UniProtKB/Swiss-Prot (Q9XT58.2); transmembrane region
propagated from UniProtKB/Swiss-Prot (Q9XT58.2); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
eukaryotic translation initiation factor 4E binding protein 1
eukaryotic translation initiation factor 4E-binding protein 1
ASH2 like, histone lysine methyltransferase complex subunit, transcript variant X1
ASH2 like, histone lysine methyltransferase complex subunit, transcript variant X2
set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X1
set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X2
steroidogenic acute regulatory protein; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001009243.1
The RefSeq transcript has 6 substitutions, 6 non-frameshifting indels compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001009243.1
steroidogenic acute regulatory protein, mitochondrial precursor
Mitochondrion. /evidence=ECO:0000250; propagated from UniProtKB/Swiss-Prot (P79245.2)
Phosphoserine, by PKA. /evidence=ECO:0000250|UniProtKB:P49675; propagated from UniProtKB/Swiss-Prot (P79245.2); phosphorylation site
LSM1 homolog, mRNA degradation associated
U6 snRNA-associated Sm-like protein LSm1
BAG cochaperone 4, transcript variant X1
BAG family molecular chaperone regulator 4 isoform X1
BAG cochaperone 4, transcript variant X2
BAG family molecular chaperone regulator 4 isoform X2
DDHD domain containing 2, transcript variant X1
DDHD domain containing 2, transcript variant X3
DDHD domain containing 2, transcript variant X2
DDHD domain containing 2, transcript variant X4
phospholipid phosphatase 5, transcript variant X3
phospholipid phosphatase 5, transcript variant X4
phospholipid phosphatase 5, transcript variant X6
phospholipid phosphatase 5, transcript variant X1
phospholipid phosphatase 5, transcript variant X7
phospholipid phosphatase 5, transcript variant X5
phospholipid phosphatase 5, transcript variant X2
nuclear receptor binding SET domain protein 3, transcript variant X6
nuclear receptor binding SET domain protein 3, transcript variant X5
nuclear receptor binding SET domain protein 3, transcript variant X4
nuclear receptor binding SET domain protein 3, transcript variant X1
nuclear receptor binding SET domain protein 3, transcript variant X2
nuclear receptor binding SET domain protein 3, transcript variant X3
nuclear receptor binding SET domain protein 3, transcript variant X7
histone-lysine N-methyltransferase NSD3 isoform X3
histone-lysine N-methyltransferase NSD3 isoform X2
histone-lysine N-methyltransferase NSD3 isoform X1
histone-lysine N-methyltransferase NSD3 isoform X4
nuclear receptor binding SET domain protein 3, transcript variant X8
histone-lysine N-methyltransferase NSD3 isoform X5
leucine zipper and EF-hand containing transmembrane protein 2, transcript variant X3
leucine zipper and EF-hand containing transmembrane protein 2, transcript variant X1
leucine zipper and EF-hand containing transmembrane protein 2, transcript variant X5
leucine zipper and EF-hand containing transmembrane protein 2, transcript variant X4
leucine zipper and EF-hand containing transmembrane protein 2, transcript variant X2
LETM1 domain-containing protein LETM2, mitochondrial isoform X1
LETM1 domain-containing protein LETM2, mitochondrial isoform X2
LETM1 domain-containing protein LETM2, mitochondrial isoform X3
fibroblast growth factor receptor 1, transcript variant X8
fibroblast growth factor receptor 1, transcript variant X7
fibroblast growth factor receptor 1, transcript variant X6
fibroblast growth factor receptor 1, transcript variant X5
fibroblast growth factor receptor 1, transcript variant X4
fibroblast growth factor receptor 1, transcript variant X3
fibroblast growth factor receptor 1, transcript variant X1
fibroblast growth factor receptor 1, transcript variant X2
fibroblast growth factor receptor 1 isoform X7
fibroblast growth factor receptor 1 isoform X6
fibroblast growth factor receptor 1 isoform X5
fibroblast growth factor receptor 1 isoform X4
fibroblast growth factor receptor 1 isoform X3
fibroblast growth factor receptor 1 isoform X2
fibroblast growth factor receptor 1 isoform X1
transforming acidic coiled-coil containing protein 1, transcript variant X2
transforming acidic coiled-coil containing protein 1, transcript variant X9
transforming acidic coiled-coil-containing protein 1 isoform X2
transforming acidic coiled-coil containing protein 1, transcript variant X4
transforming acidic coiled-coil containing protein 1, transcript variant X12
transforming acidic coiled-coil containing protein 1, transcript variant X13
transforming acidic coiled-coil-containing protein 1 isoform X4
transforming acidic coiled-coil-containing protein 1 isoform X12
transforming acidic coiled-coil-containing protein 1 isoform X13
transforming acidic coiled-coil containing protein 1, transcript variant X1
transforming acidic coiled-coil containing protein 1, transcript variant X7
transforming acidic coiled-coil containing protein 1, transcript variant X5
transforming acidic coiled-coil containing protein 1, transcript variant X8
transforming acidic coiled-coil containing protein 1, transcript variant X3
transforming acidic coiled-coil containing protein 1, transcript variant X6
transforming acidic coiled-coil containing protein 1, transcript variant X10
transforming acidic coiled-coil containing protein 1, transcript variant X11
transforming acidic coiled-coil-containing protein 1 isoform X1
transforming acidic coiled-coil-containing protein 1 isoform X7
transforming acidic coiled-coil-containing protein 1 isoform X5
transforming acidic coiled-coil-containing protein 1 isoform X8
transforming acidic coiled-coil-containing protein 1 isoform X3
transforming acidic coiled-coil-containing protein 1 isoform X6
transforming acidic coiled-coil-containing protein 1 isoform X10
transforming acidic coiled-coil-containing protein 1 isoform X11
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transforming acidic coiled-coil-containing protein 1 isoform X9
pleckstrin homology domain containing A2, transcript variant X5
pleckstrin homology domain containing A2, transcript variant X4
pleckstrin homology domain containing A2, transcript variant X1
pleckstrin homology domain containing A2, transcript variant X7
pleckstrin homology domain containing A2, transcript variant X6
pleckstrin homology domain containing A2, transcript variant X2
pleckstrin homology domain containing A2, transcript variant X3
pleckstrin homology domain-containing family A member 2 isoform X1
pleckstrin homology domain-containing family A member 2 isoform X3
pleckstrin homology domain-containing family A member 2 isoform X2
HtrA serine peptidase 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
HtrA serine peptidase 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
HtrA serine peptidase 4, transcript variant X1
TM2 domain containing 2, transcript variant X2
TM2 domain containing 2, transcript variant X1
TM2 domain-containing protein 2 isoform X2
TM2 domain-containing protein 2 isoform X1
ADAM metallopeptidase domain 9, transcript variant X1
ADAM metallopeptidase domain 9, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 9
disintegrin and metalloproteinase domain-containing protein 32
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 32% coverage of the annotated genomic feature by RNAseq alignments
disintegrin and metalloproteinase domain-containing protein 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 19% coverage of the annotated genomic feature by RNAseq alignments
disintegrin and metalloproteinase domain-containing protein 2
A disintegrin and metallopeptidase domain 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 30% coverage of the annotated genomic feature by RNAseq alignments
developmental pluripotency-associated protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: A disintegrin and metallopeptidase domain 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
disintegrin and metalloproteinase domain-containing protein 18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins
indoleamine 2,3-dioxygenase 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001141953.1
The RefSeq transcript has 5 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001135425.1
indoleamine 2,3-dioxygenase 2, transcript variant X1
indoleamine 2,3-dioxygenase 2, transcript variant X2
indoleamine 2,3-dioxygenase 2 isoform X1
indoleamine 2,3-dioxygenase 2 isoform X2
indoleamine 2,3-dioxygenase 2, transcript variant X4
indoleamine 2,3-dioxygenase 2, transcript variant X5
indoleamine 2,3-dioxygenase 2, transcript variant X3
indoleamine 2,3-dioxygenase 2 isoform X3
indoleamine 2,3-dioxygenase 2 isoform X4
indoleamine 2,3-dioxygenase 2, transcript variant X6
indoleamine 2,3-dioxygenase 2 isoform X5
indoleamine 2,3-dioxygenase 2 isoform X6
transcriptional and immune response regulator
uncharacterized LOC121818051, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC121818051, transcript variant X2
zinc finger matrin-type 4, transcript variant X2
zinc finger matrin-type protein 4 isoform X2
zinc finger matrin-type 4, transcript variant X1
zinc finger matrin-type 4, transcript variant X3
zinc finger matrin-type 4, transcript variant X4
zinc finger matrin-type protein 4 isoform X1
zinc finger matrin-type protein 4 isoform X3
zinc finger matrin-type protein 4 isoform X4
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
COORDINATES: nucleotide motif:Rfam:12.0:RF00156
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DNA replication complex GINS protein SLD5
glycerol-3-phosphate acyltransferase 4, transcript variant X5
glycerol-3-phosphate acyltransferase 4, transcript variant X2
glycerol-3-phosphate acyltransferase 4, transcript variant X3
glycerol-3-phosphate acyltransferase 4, transcript variant X4
glycerol-3-phosphate acyltransferase 4, transcript variant X1
glycerol-3-phosphate acyltransferase 4 isoform X1
glycerol-3-phosphate acyltransferase 4, transcript variant X6
glycerol-3-phosphate acyltransferase 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC114110969, transcript variant X2
uncharacterized LOC114110969, transcript variant X1
lysine acetyltransferase 6A, transcript variant X1
lysine acetyltransferase 6A, transcript variant X2
lysine acetyltransferase 6A, transcript variant X3
histone acetyltransferase KAT6A isoform X1
histone acetyltransferase KAT6A isoform X2
histone acetyltransferase KAT6A isoform X3
adaptor related protein complex 3 subunit mu 2, transcript variant X2
adaptor related protein complex 3 subunit mu 2, transcript variant X1
uncharacterized LOC121818030, transcript variant X2
uncharacterized LOC121818030, transcript variant X1
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X1
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X3
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X2
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X4
inhibitor of nuclear factor kappa-B kinase subunit beta isoform X3
inhibitor of nuclear factor kappa-B kinase subunit beta isoform X4
inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1
inhibitor of nuclear factor kappa-B kinase subunit beta isoform X2
DNA polymerase beta, transcript variant X2
DNA polymerase beta, transcript variant X1
DNA polymerase beta, transcript variant X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: E3 ubiquitin-protein ligase ZFP91-like
dickkopf WNT signaling pathway inhibitor 4
voltage dependent anion channel 3, transcript variant X2
voltage dependent anion channel 3, transcript variant X4
voltage dependent anion channel 3, transcript variant X1
voltage dependent anion channel 3, transcript variant X3
voltage-dependent anion-selective channel protein 3 isoform X1
voltage-dependent anion-selective channel protein 3 isoform X2
solute carrier family 20 member 2, transcript variant X7
solute carrier family 20 member 2, transcript variant X6
solute carrier family 20 member 2, transcript variant X4
solute carrier family 20 member 2, transcript variant X2
solute carrier family 20 member 2, transcript variant X5
solute carrier family 20 member 2, transcript variant X3
solute carrier family 20 member 2, transcript variant X1
sodium-dependent phosphate transporter 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
small integral membrane protein 19, transcript variant X6
small integral membrane protein 19, transcript variant X1
small integral membrane protein 19, transcript variant X2
small integral membrane protein 19, transcript variant X5
small integral membrane protein 19, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
small integral membrane protein 19 isoform X1
small integral membrane protein 19, transcript variant X4
small integral membrane protein 19 isoform X3
small integral membrane protein 19 isoform X2
cholinergic receptor nicotinic beta 3 subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
neuronal acetylcholine receptor subunit beta-3
cholinergic receptor nicotinic alpha 6 subunit
neuronal acetylcholine receptor subunit alpha-6
ring finger protein 170, transcript variant X3
ring finger protein 170, transcript variant X1
ring finger protein 170, transcript variant X4
ring finger protein 170, transcript variant X2
E3 ubiquitin-protein ligase RNF170 isoform X1
E3 ubiquitin-protein ligase RNF170 isoform X2
hook microtubule tethering protein 3, transcript variant X4
hook microtubule tethering protein 3, transcript variant X1
hook microtubule tethering protein 3, transcript variant X2
hook microtubule tethering protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
farnesyltransferase, CAAX box, alpha; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001161883.1
similar to AA sequence (same species):RefSeq:NP_001155355.1
protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
protein O-mannose kinase, transcript variant X4
protein O-mannose kinase, transcript variant X6
protein O-mannose kinase, transcript variant X8
protein O-mannose kinase, transcript variant X13
protein O-mannose kinase, transcript variant X7
protein O-mannose kinase, transcript variant X9
protein O-mannose kinase, transcript variant X12
protein O-mannose kinase, transcript variant X11
protein O-mannose kinase, transcript variant X3
protein O-mannose kinase, transcript variant X10
protein O-mannose kinase, transcript variant X1
protein O-mannose kinase, transcript variant X2
protein O-mannose kinase, transcript variant X5
heparan-alpha-glucosaminide N-acetyltransferase, transcript variant X2
heparan-alpha-glucosaminide N-acetyltransferase isoform X2
heparan-alpha-glucosaminide N-acetyltransferase, transcript variant X1
heparan-alpha-glucosaminide N-acetyltransferase, transcript variant X4
heparan-alpha-glucosaminide N-acetyltransferase isoform X1
heparan-alpha-glucosaminide N-acetyltransferase, transcript variant X3
heparan-alpha-glucosaminide N-acetyltransferase isoform X3
heparan-alpha-glucosaminide N-acetyltransferase isoform X4
heparan-alpha-glucosaminide N-acetyltransferase, transcript variant X5
heparan-alpha-glucosaminide N-acetyltransferase isoform X5
integrator complex subunit 10, transcript variant X4
integrator complex subunit 10, transcript variant X3
integrator complex subunit 10, transcript variant X2
integrator complex subunit 10, transcript variant X1
integrator complex subunit 10 isoform X3
integrator complex subunit 10 isoform X2
integrator complex subunit 10 isoform X1
integrator complex subunit 10 isoform X4
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X9
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X2
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X3
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X6
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X1
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X5
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X8
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X7
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X10
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X4
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X11
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X12
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X14
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X13
chondroitin sulfate N-acetylgalactosaminyltransferase 1 isoform X1
chondroitin sulfate N-acetylgalactosaminyltransferase 1 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
SH2 domain containing 4A, transcript variant X3
SH2 domain containing 4A, transcript variant X2
SH2 domain containing 4A, transcript variant X1
SH2 domain-containing protein 4A isoform X2
SH2 domain-containing protein 4A isoform X1
pleckstrin and Sec7 domain containing 3, transcript variant X2
pleckstrin and Sec7 domain containing 3, transcript variant X1
pleckstrin and Sec7 domain containing 3, transcript variant X4
pleckstrin and Sec7 domain containing 3, transcript variant X5
pleckstrin and Sec7 domain containing 3, transcript variant X3
PH and SEC7 domain-containing protein 3 isoform X1
PH and SEC7 domain-containing protein 3 isoform X2
PH and SEC7 domain-containing protein 3 isoform X3
pleckstrin and Sec7 domain containing 3, transcript variant X6
pleckstrin and Sec7 domain containing 3, transcript variant X8
PH and SEC7 domain-containing protein 3 isoform X6
PH and SEC7 domain-containing protein 3 isoform X4
pleckstrin and Sec7 domain containing 3, transcript variant X7
PH and SEC7 domain-containing protein 3 isoform X5
pleckstrin and Sec7 domain containing 3, transcript variant X9
PH and SEC7 domain-containing protein 3 isoform X7
pleckstrin and Sec7 domain containing 3, transcript variant X12
PH and SEC7 domain-containing protein 3 isoform X10
pleckstrin and Sec7 domain containing 3, transcript variant X10
pleckstrin and Sec7 domain containing 3, transcript variant X11
PH and SEC7 domain-containing protein 3 isoform X8
PH and SEC7 domain-containing protein 3 isoform X9
pleckstrin and Sec7 domain containing 3, transcript variant X13
PH and SEC7 domain-containing protein 3 isoform X11
arylamine N-acetyltransferase 1, transcript variant X1
arylamine N-acetyltransferase 1, transcript variant X4
arylamine N-acetyltransferase 1, transcript variant X3
arylamine N-acetyltransferase 1, transcript variant X2
arylamine N-acetyltransferase 1, transcript variant X5
arylamine N-acetyltransferase 1, transcript variant X6
uncharacterized LOC121818052, transcript variant X1
uncharacterized LOC121818052, transcript variant X2
uncharacterized protein LOC121818052 isoform X1
uncharacterized protein LOC121818052 isoform X2
leucine rich repeat containing 3B, transcript variant X2
leucine rich repeat containing 3B, transcript variant X5
leucine rich repeat containing 3B, transcript variant X6
leucine rich repeat containing 3B, transcript variant X3
leucine rich repeat containing 3B, transcript variant X4
leucine rich repeat containing 3B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
leucine-rich repeat-containing protein 3B
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: histone H3-like centromeric protein A
uncharacterized LOC106991954, transcript variant X2
uncharacterized LOC106991954, transcript variant X4
uncharacterized LOC106991954, transcript variant X1
uncharacterized LOC106991954, transcript variant X3
3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 2 long SRA reads, 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
peptide-N(4)-(N-acetyl-beta- glucosaminyl)asparagine amidase isoform X1
peptide-N(4)-(N-acetyl-beta- glucosaminyl)asparagine amidase isoform X3
peptide-N(4)-(N-acetyl-beta- glucosaminyl)asparagine amidase isoform X4
peptide-N(4)-(N-acetyl-beta- glucosaminyl)asparagine amidase isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 82% coverage of the annotated genomic feature by RNAseq alignments
DNA topoisomerase II beta, transcript variant X1
DNA topoisomerase II beta, transcript variant X2
DNA topoisomerase II beta, transcript variant X3
retinoic acid receptor beta, transcript variant X1
retinoic acid receptor beta, transcript variant X6
retinoic acid receptor beta, transcript variant X2
retinoic acid receptor beta, transcript variant X4
retinoic acid receptor beta, transcript variant X5
retinoic acid receptor beta, transcript variant X3
thyroid hormone receptor beta; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001190391.1
The RefSeq transcript has 4 substitutions and aligns at 98% coverage compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001177320.1
The RefSeq protein has 1 substitution and aligns at 98% coverage compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
propagated from UniProtKB/Swiss-Prot (Q28571.1); Region: Modulating
propagated from UniProtKB/Swiss-Prot (Q28571.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
nuclear receptor subfamily 1 group D member 2, transcript variant X2
nuclear receptor subfamily 1 group D member 2, transcript variant X3
nuclear receptor subfamily 1 group D member 2, transcript variant X1
nuclear receptor subfamily 1 group D member 2 isoform X1
nuclear receptor subfamily 1 group D member 2 isoform X2
ribosomal protein L15, transcript variant X1
ribosomal protein L15, transcript variant X2
NFKB inhibitor interacting Ras like 1, transcript variant X2
NFKB inhibitor interacting Ras like 1, transcript variant X1
NF-kappa-B inhibitor-interacting Ras-like protein 1 isoform X1
NFKB inhibitor interacting Ras like 1, transcript variant X3
NF-kappa-B inhibitor-interacting Ras-like protein 1 isoform X2
uncharacterized LOC121818053, transcript variant X2
uncharacterized LOC121818053, transcript variant X1
ubiquitin-conjugating enzyme E2E 2; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
ubiquitin conjugating enzyme E2 E2, transcript variant X1
similar to RNA sequence, mRNA (same species):RefSeq:NM_001134307.1
ubiquitin-conjugating enzyme E2 E2 isoform X1
similar to AA sequence (same species):RefSeq:NP_001127779.1
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
zinc finger protein 385D, transcript variant X1
zinc finger protein 385D, transcript variant X2